Table 2.
Time to | Exposed to antipsychotic medication | Not exposed to antipsychotic medication | Adjusted HR Model 1 (95% CI)a | Adjusted HR Model 2 (95% CI)b | ||||
---|---|---|---|---|---|---|---|---|
Events | Follow-up years | Rate per 100 person-years (95% CI) | Events | Follow-up years | Rate per 100 person-years (95% CI) | |||
All older people with all-cause dementia (n = 9674) | 2342 | 100.9 | 23.2 (22.2–24.2) | 2777 | 121.9 | 22.8 (22.0–23.6) | 1.0 (0.96–1.09) | 1.06 (0.99–1.13) |
Older people with Alzheimer’s disease (n = 6996) | 1689 | 74.0 | 22.8 (22.2–23.9) | 2006 | 90.2 | 22.2 (21.2–23.2) | 1.02 (0.96–1.09) | 1.06 (0.99–1.14) |
Older people with all-cause dementia known to primary care only (n = 5089) | 1122 | 37.7 | 29.8 (28.1–31.6) | 1834 | 61.0 | 30.0 (28.7–31.5) | 1.0 (0.91–1.10) | 1.03 (0.96–1.10) |
CI Confidence interval, HR hazard ratio
aModel 1 = adjusted for history of medical co-morbidities as listed in Table 1, age at dementia diagnosis and gender
bModel 2 = adjusted for history of medical co-morbidities as listed in Table 1, age at dementia diagnosis, gender, and exposure to anxiolytic and/or hypnotic medication